[6] Similar to the human studies, studies in animals showcase both the effectiveness and safety of this peptide in reducing body weight, increasing fat oxidation, and increasing lipolysis in obese animals
At the same time, obesity can lead to irregular periods or heavier periods
Retatrutide Phase 3 results look promising, but the drug is not FDA-approved for public use
doi: 10.1016/S0140-6736(20)32511-3 3 DjordjevicDBZdravkovicMNagorniAManolisATsioufisCLovicD
The antioxidant properties of carnitine and its role in mitochondrial function have made it a subject of interest in neurological research
Sermorelin may indirectly support hepatic metabolism by restoring healthy GH/IGF-1 signaling, but it shouldnt be viewed as a targeted treatment for fatty liver disease until it has been formally studied in that specific population. Sermorelin may also improve sleep quality, an issue affecting 40 to 60 percent of women in the menopause years